We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$3.15B
AUM Growth
+$265M
Cap. Flow
+$106M
Cap. Flow %
3.38%
Top 10 Hldgs %
64.28%
Holding
317
New
29
Increased
101
Reduced
131
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 3.7%
2 Financials 2.24%
3 Communication Services 1.12%
4 Consumer Discretionary 0.59%
5 Industrials 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
151
Accenture
ACN
$89.9B
$946K 0.03%
3,166
+230
+8% +$70K
VGSH icon
152
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$934K 0.03%
15,888
+174
+1% +$10.2K
USB icon
153
US Bancorp
USB
$99.6B
$918K 0.03%
20,296
+177
+0.9% +$7.44K
BNDX icon
154
Vanguard Total International Bond ETF
BNDX
$82B
$912K 0.03%
+18,413
New +$906K
DHR icon
155
Danaher
DHR
$135B
$908K 0.03%
4,594
-216
-4% -$41.9K
SUSA icon
156
iShares ESG Optimized MSCI USA ETF
SUSA
$3.98B
$871K 0.03%
6,868
QSR icon
157
Restaurant Brands International
QSR
$25.1B
$868K 0.03%
13,088
+3
+0% +$200
SPG icon
158
Simon Property Group
SPG
$74.5B
$866K 0.03%
5,386
-465
-8% -$73.5K
DGRO icon
159
iShares Core Dividend Growth ETF
DGRO
$42.6B
$861K 0.03%
13,463
DVY icon
160
iShares Select Dividend ETF
DVY
$24B
$830K 0.03%
6,251
HYG icon
161
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$813K 0.03%
10,082
+5,694
+130% +$449K
GLD icon
162
SPDR Gold Trust
GLD
$131B
$807K 0.03%
2,649
-1,377
-34% -$417K
COF icon
163
Capital One
COF
$124B
$804K 0.03%
3,778
+867
+30% +$162K
DOCU
164
DocuSign
DOCU
$9.63B
$788K 0.03%
10,117
+3
+0% +$243
CP icon
165
Canadian Pacific Kansas City
CP
$82B
$780K 0.02%
9,836
-980
-9% -$75.4K
SDG icon
166
iShares MSCI Global Sustainable Development Goals ETF
SDG
$167M
$772K 0.02%
10,180
-21,497
-68% -$1.58M
BSV icon
167
Vanguard Short-Term Bond ETF
BSV
$44.6B
$770K 0.02%
9,784
QEMM icon
168
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$53.9M
$762K 0.02%
12,092
XLK icon
169
State Street Technology Select Sector SPDR ETF
XLK
$115B
$757K 0.02%
5,980
-188
-3% -$20.9K
KMI icon
170
Kinder Morgan
KMI
$73.1B
$732K 0.02%
24,887
+1,149
+5% +$31.5K
BRK.B icon
171
CALL
Berkshire Hathaway Class B
BRK.B
$1.07T
$729K 0.02%
+1,500
New +$762K
GS icon
172
Goldman Sachs
GS
$313B
$710K 0.02%
1,003
-22
-2% -$12.7K
ESGU icon
173
iShares ESG Aware MSCI USA ETF
ESGU
$17.6B
$688K 0.02%
+5,082
New +$634K
VOT icon
174
Vanguard Mid-Cap Growth ETF
VOT
$19B
$682K 0.02%
2,398
PFE icon
175
Pfizer
PFE
$140B
$670K 0.02%
27,652
-1,475
-5% -$34.4K

Similar funds

Aspiriant LLC's Q2 2025 Portfolio in Review

As of Q2 2025, Aspiriant LLC held 317 positions worth $3.15B, up 9.2% from $2.88B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Aspiriant LLC deployed $106M of net new capital in Q2 2025, opening 29 new positions and adding to 101 existing holdings. Its largest new stake was Vanguard Short-Term Inflation-Protected Securities Index Fund: 81,710 shares worth $4.11M.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, down from 4.1% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $20.6M trimmed.

  • Aspiriant LLC's largest Q2 2025 buy was Vanguard Short-Term Inflation-Protected Securities Index Fund: 81,710 shares worth $4.11M.
  • Aspiriant LLC added most to Vanguard S&P Small-Cap 600 Value ETF in Q2 2025, an estimated $25.1M increase.
  • Aspiriant LLC's biggest Q2 2025 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $20.6M.
  • Aspiriant LLC fully exited iShares 0-3 Month Treasury Bond ETF in Q2 2025, selling an estimated $395K.
  • Aspiriant LLC's ten largest holdings make up 64% of its $3.15B portfolio in Q2 2025.
  • Aspiriant LLC opened 29 new positions and closed 8 in Q2 2025.
  • Aspiriant LLC's portfolio value rose 9.2% quarter-over-quarter to $3.15B.

Based on Aspiriant LLC's 13F filing for Q2 2025, filed 29 Jul 2025.